1. Background {#sec1-healthcare-05-00083}
=============

Socioeconomic status (SES) is a major determinant of risk for diabetes (DM) \[[@B1-healthcare-05-00083],[@B2-healthcare-05-00083]\]. Research from the U.S. \[[@B3-healthcare-05-00083]\], Canada \[[@B4-healthcare-05-00083]\], and developing countries \[[@B5-healthcare-05-00083]\] has suggested that low education \[[@B1-healthcare-05-00083]\], low income \[[@B3-healthcare-05-00083],[@B4-healthcare-05-00083],[@B6-healthcare-05-00083]\], being single \[[@B5-healthcare-05-00083]\], and minority status \[[@B7-healthcare-05-00083],[@B8-healthcare-05-00083]\] are all risk factors for DM. Similar trends have been reported for prevalence \[[@B3-healthcare-05-00083]\] and incidence \[[@B9-healthcare-05-00083]\]. Distribution of DM in the community follows a social gradient, with the highest prevalence in the lowest SES group, and then decline as SES increases \[[@B10-healthcare-05-00083]\]. In addition, SES is also a determinant of DM complications and mortality \[[@B1-healthcare-05-00083]\]. Among patients with DM, SES is a determinant of QOL \[[@B11-healthcare-05-00083]\], depression \[[@B12-healthcare-05-00083],[@B13-healthcare-05-00083]\], medical comorbidities, medication adherence, and glucose control \[[@B14-healthcare-05-00083]\].

Minority status is associated with higher risk \[[@B7-healthcare-05-00083]\] and burden of DM in general population \[[@B8-healthcare-05-00083]\]. Blacks have a higher risk of DM \[[@B8-healthcare-05-00083],[@B15-healthcare-05-00083]\], low SES \[[@B16-healthcare-05-00083],[@B17-healthcare-05-00083],[@B18-healthcare-05-00083]\], and worse outcomes associated with DM \[[@B15-healthcare-05-00083],[@B16-healthcare-05-00083],[@B17-healthcare-05-00083],[@B18-healthcare-05-00083],[@B19-healthcare-05-00083],[@B20-healthcare-05-00083],[@B21-healthcare-05-00083],[@B22-healthcare-05-00083],[@B23-healthcare-05-00083],[@B24-healthcare-05-00083]\]. Risk factors of DM such as obesity \[[@B23-healthcare-05-00083]\], poor nutrition \[[@B21-healthcare-05-00083]\], and low exercise \[[@B22-healthcare-05-00083]\] are all more common among Blacks, particularly low SES Blacks who live in urban areas. Blacks with DM also suffer worse health outcomes and additional risk of mortality and complications \[[@B24-healthcare-05-00083]\]. Compared to Whites with DM, Blacks with DM also receive less frequent care and poorer quality of care \[[@B25-healthcare-05-00083]\].

In contrast to the traditional belief that worse health outcomes among minorities is wholly attributable to SES differences, growing evidence suggests that economic and social resources such as SES may affect health outcomes differently across race and gender groups \[[@B26-healthcare-05-00083]\]. In this emerging view, instead of explaining (mediating) the effect of race \[[@B27-healthcare-05-00083],[@B28-healthcare-05-00083]\], SES interacts with race to affect resources and health outcomes.

This study aimed to investigate the association between SES and glycemic control in a clinical sample of White and Black patients with type 2 DM. We were particularly interested in the differential role of SES factors upon glycemic control based on race, gender, and their intersection. In line with previous research in the general population that has shown interactions between SES and race \[[@B16-healthcare-05-00083],[@B17-healthcare-05-00083],[@B18-healthcare-05-00083],[@B20-healthcare-05-00083]\], SES by DM \[[@B26-healthcare-05-00083]\], and risk factors and race \[[@B19-healthcare-05-00083],[@B23-healthcare-05-00083]\], we hypothesized that associations between SES factors and glycemic control would vary across subgroups defined by race and gender. This hypothesis is partially based on prior data suggesting that Black patients with DM have worse SES and therefore may have particular sets of needs \[[@B29-healthcare-05-00083]\].

2. Materials and Methods {#sec2-healthcare-05-00083}
========================

2.1. Design and Setting {#sec2dot1-healthcare-05-00083}
-----------------------

This is a cross-sectional study, in an outpatient setting in a large Midwestern urban health care system. More information regarding methods and design of the study is available elsewhere \[[@B30-healthcare-05-00083]\].

2.2. Participant Selection {#sec2dot2-healthcare-05-00083}
--------------------------

The study used a consecutive sampling strategy. Potential participants were identified using administrative and clinical databases. Eligible patients were mailed a study invitation letter followed by a recruitment telephone call from research staff for further screening and enrollment scheduling.

2.3. Eligibility and Sampling {#sec2dot3-healthcare-05-00083}
-----------------------------

Eligibility criteria included being between 18 and 80 years of age, being able to complete self-report instruments, and having type 2 DM (as indicated by at least one of the following criteria: (1) positive history of hospitalization with a DM-related ICD-9 code (250.x, 357.2, 362.0, or 366.41), (2) two or more outpatient visits with a DM-related ICD-9 code, or (3) prescription for a glucose control medication or monitoring supplies). Type 1 DM was further ruled out by thorough chart review and telephone screening by research staff.

Current analysis only included those who were receiving insulin (*n* = 112). Our sample is not a representative sample, so the results may be affected by selection bias, particularly because not every person who was contacted agreed to participate in the study.

2.4. Ethics {#sec2dot4-healthcare-05-00083}
-----------

The study protocol was approved by institutional review boards at the University of Michigan and the Henry Ford Health System. All participants provided informed consent. Data were kept confidential.

2.5. Measures {#sec2dot5-healthcare-05-00083}
-------------

Main outcome: Glycemic control (Hemoglobin A1c; HbA1c) was measured with the DCA 2000 (GMI, Ramsey, MN, USA), which analyzes capillary blood samples through a monoclonal antibody method \[[@B30-healthcare-05-00083]\].

Socioeconomic status (SES) and governmental insurance: We measured SES using the U.S. Census Bureau Index of Socioeconomic Status \[[@B31-healthcare-05-00083]\], adjusted for the regional Consumer Price Index at the time of survey \[[@B30-healthcare-05-00083]\]. A higher score was indicative of better SES. Governmental insurance in this study was Medicaid coverage \[[@B32-healthcare-05-00083]\].

Race: Participants were asked to classify themselves using U.S. Census racial/ethnic categories. Race included White (Caucasian) or Black (African American).

Demographic Factors: The study collected data on self-reported age and gender. Age was treated as a continuous measure, and gender was female versus male \[reference category\].

Clinical Variables: Diabetes duration was our main clinical variable that was conceptualized as a covariate. Diabetes duration was calculated as number of years passed since diagnosis, and was self-reported. Diabetes duration was treated as a continuous measure in this study.

2.6. Analysis {#sec2dot6-healthcare-05-00083}
-------------

Data were analyzed using Stata 13.0 (Stata Corp., College Station, TX, USA) as well as Statistical Package for Social Sciences v.20 (SPSS 20). Descriptive statistics such as mean (SD) and frequency (%) were used to describe the variables in the pooled sample as well as race by gender subgroups. For bivariate analysis, we tested Pearson correlations between study variables across groups based on the intersection of race and gender. We used linear regression models to estimate adjusted associations between race, SES, and HbA1c, net of demographics. The outcome variable was HbA1c, and covariates were age and gender. Model 1 in the pooled sample only had main effects. Model 2 in the pooled sample also included the interaction between race and gender. Finally, we ran four stratified models for Black and White men and women. Standardized B, 95% CI, and *p*-values were reported. A *p*-value of \<0.05 was considered significant.

3. Results {#sec3-healthcare-05-00083}
==========

The current analysis included 112 DM patients, which was composed of 38 Black women, 34 Black men, 14 White women, and 26 White men. [Table 1](#healthcare-05-00083-t001){ref-type="table"} describes the descriptive statistics in the pooled sample and subgroups based on the race by gender ([Table 1](#healthcare-05-00083-t001){ref-type="table"}).

[Table 2](#healthcare-05-00083-t002){ref-type="table"} shows correlation coefficients between study variables in the pooled sample and based on race by gender subgroups. SES was marginally correlated with HbA1c in Black men. SES was not correlated with HbA1c in Black women, White men, and White women. Age and governmental insurance were not correlated among Black men, although they were correlated among White men, White women, and Black women.

As shown in [Table 3](#healthcare-05-00083-t003){ref-type="table"}, in the absence of race by gender interaction term, age (B = −0.25, 95% CI = −0.11--0.00, *p* = 0.046) was associated with HbA1c in the pooled sample; gender was possibly associated with HbA1c (B = −0.19, 95% CI = −1.47--0.04, *p* = 0.064); and race, SES, DM duration, and governmental insurance were not associated with HbA1c. Race by gender interaction term was marginally significant on glycemic control (B = 0.34, 95% CI = −0.24--3.00, *p* = 0.094).

As shown in [Table 4](#healthcare-05-00083-t004){ref-type="table"}, age, SES, governmental insurance, and DM duration were not associated with HbA1c in White men, White women, and Black women. In Black men, however, age (B = −0.35, 95% CI = −0.20--0.01, *p* = 0.040), and governmental insurance (B = 0.35, 95% CI = 0.05--2.42, *p* = 0.042) were each significantly associated with HbA1c, and SES (B = −0.33, 95% CI = −0.10--0.00, *p* = 0.050) was possibly associated with HbA1c.

4. Discussion {#sec4-healthcare-05-00083}
=============

In racially diverse samples of insulin-treated patients with type 2 DM, data analyses revealed two findings: First, we found a marginally significant interaction between race and gender on glycemic control, suggesting worse glycemic control in Black women compared to Black men and White women. Second, although SES and governmental insurance were not associated with HbA1c in the pooled sample, race by gender difference were found in these effects. SES and governmental insurance emerged as a predictor of glycemic control for Black men but not White men, White women, or Black women.

Regarding our first finding, worse glycemic control of Black women may be due to their use of over-eating and binge eating in response to stress \[[@B33-healthcare-05-00083],[@B34-healthcare-05-00083]\]. This finding suggests a more aggressive DM control for Black women who may have worse glycemic control compared to other race by gender groups.

Our second finding that SES resources may differently affect sub-populations is in line with previous research that has shown that the same increase in SES generates various levels of change in health outcomes of race, gender, and SES groups \[[@B26-healthcare-05-00083]\]. Our finding refutes the traditional assumption that SES is universally protective against undesired health outcomes of all social and demographic groups. Recent research has shown that race and gender do not only alter exposure to risk and protective factors \[[@B27-healthcare-05-00083],[@B28-healthcare-05-00083]\] but also alter vulnerability to them \[[@B20-healthcare-05-00083],[@B35-healthcare-05-00083],[@B36-healthcare-05-00083],[@B37-healthcare-05-00083],[@B38-healthcare-05-00083],[@B39-healthcare-05-00083],[@B40-healthcare-05-00083],[@B41-healthcare-05-00083]\]. We also found that Medicaid coverage was associated with worse glycemic control of Black men, which may be due to higher health need of individuals who qualify for Medicaid coverage. So, we believe we attribute this finding to selection rather than causation.

Racial minority status alters the health gains that are expected to follow SES \[[@B35-healthcare-05-00083]\]. In a study among the elderly, race interacted with education level on alcohol consumption, with education having a smaller effect on drinking patterns for Blacks than it does for Whites. While among Whites, high-school graduation and college graduation were both associated with increased odds of ever drinking, among Blacks, high-school graduation, but not college graduation, was associated with ever drinking \[[@B35-healthcare-05-00083]\]. Other research has shown that education \[[@B37-healthcare-05-00083]\] and employment \[[@B20-healthcare-05-00083]\] have larger protective effects against premature mortality for Whites than Blacks. The same is true for neighborhood quality \[[@B42-healthcare-05-00083]\]. However, our present findings contradict these results, by showing effect of SES for Black men but not for any other groups.

SES effects depend upon race \[[@B35-healthcare-05-00083]\] and gender \[[@B36-healthcare-05-00083],[@B38-healthcare-05-00083],[@B40-healthcare-05-00083],[@B43-healthcare-05-00083],[@B44-healthcare-05-00083],[@B45-healthcare-05-00083],[@B46-healthcare-05-00083]\]. A wide range of social environment may differentially affect metabolic risk across social groups \[[@B36-healthcare-05-00083],[@B38-healthcare-05-00083],[@B40-healthcare-05-00083],[@B43-healthcare-05-00083],[@B44-healthcare-05-00083],[@B45-healthcare-05-00083],[@B46-healthcare-05-00083]\]. Contradicting our findings, however, most previous research has documented a more salient role of social and psychological constructs on metabolic risk of females than males \[[@B36-healthcare-05-00083],[@B38-healthcare-05-00083],[@B40-healthcare-05-00083],[@B43-healthcare-05-00083],[@B44-healthcare-05-00083],[@B45-healthcare-05-00083],[@B46-healthcare-05-00083]\].

Our findings are in line with the studies showing that SES may have a larger effect on the health of men than women \[[@B47-healthcare-05-00083],[@B48-healthcare-05-00083]\]. Specifically, men may be more susceptible to the effects of unemployment than women \[[@B47-healthcare-05-00083],[@B48-healthcare-05-00083],[@B49-healthcare-05-00083]\]. Larger health gain of men from employment was confirmed by a meta-analysis \[[@B50-healthcare-05-00083]\]. However, not every study has shown larger effects of SES for males than females \[[@B51-healthcare-05-00083],[@B52-healthcare-05-00083]\].

Not only race and gender---but their also intersection---shape how SES indicators affect health \[[@B27-healthcare-05-00083],[@B28-healthcare-05-00083],[@B53-healthcare-05-00083],[@B54-healthcare-05-00083]\]. For example, in a recent study, the protective effects of education and income on sustained insomnia, physical inactivity, and BMI varied across race by gender groups. Education did not protect Black men against insomnia, physical inactivity, and BMI. Education did not protect Black women against high BMI. Income had a protective effect against BMI among White and Black women but not White and Black men \[[@B43-healthcare-05-00083]\]. Nonetheless, intersections of social identities alter the health consequences of social risk and protective factors \[[@B52-healthcare-05-00083]\].

More research is needed on how race, gender, and SES impact health of individuals with DM. While this study in clinical sample showed a larger effect of SES on health among Black men, most previous research on the community sample has shown smaller effects of SES on health for Blacks than Whites \[[@B20-healthcare-05-00083],[@B37-healthcare-05-00083],[@B39-healthcare-05-00083]\]. Our findings did not support the "Blacks' diminished return hypothesis" \[[@B55-healthcare-05-00083]\].

In our sample, Black males and females developed diabetes in a younger age compared to White men and women. This pattern is in line with the lower age of onset of chronic disease in minorities particularly Blacks \[[@B56-healthcare-05-00083]\]. Blacks and other minority populations have higher prevalence of CMC \[[@B57-healthcare-05-00083],[@B58-healthcare-05-00083]\]. Compared with Whites, Black Americans have greater physical health morbidity and mortality at every age \[[@B59-healthcare-05-00083]\]. In several studies, chronic diseases are shown to fully mediate the lower life expectancy of Blacks compared to Whites \[[@B60-healthcare-05-00083],[@B61-healthcare-05-00083]\]. Overall, chronic disease are more common and more consequential for Blacks than Whites \[[@B54-healthcare-05-00083]\].

Our findings may have clinical and policy implications. Similar to research on other health conditions \[[@B62-healthcare-05-00083],[@B63-healthcare-05-00083],[@B64-healthcare-05-00083]\], we recommend that DM interventions should be tailored by race and gender \[[@B63-healthcare-05-00083],[@B65-healthcare-05-00083],[@B66-healthcare-05-00083]\]. This is especially important as minority populations may be more receptive to programs and interventions that are tailored to their specific needs. As loss of insurance may have the largest negative effects on glycemic control of Black men. Policies that promote universal access of all populations to a new resource such as insurance may result in differential health gain across diverse populations \[[@B20-healthcare-05-00083],[@B35-healthcare-05-00083],[@B36-healthcare-05-00083],[@B37-healthcare-05-00083],[@B38-healthcare-05-00083],[@B39-healthcare-05-00083],[@B40-healthcare-05-00083],[@B41-healthcare-05-00083]\]. Optimal solutions should go beyond universal interventions by considering specific health needs of each demographic group \[[@B67-healthcare-05-00083]\].

To conclude, the effects of SES on glycemic control vary across the race by gender subgroups of insulin-treated type 2 DM patients. Specifically, SES may be particularly important for glycemic control of Black men. Further research with a large and diverse sample is needed given the degree of inconsistency across the literature.

5. Conclusions {#sec5-healthcare-05-00083}
==============

Socioeconomic factors have differential effects on health outcomes across race by gender subgroups. In particular, SES may have a larger effect on glycemic control of Black men with DM. Due to lack of generalizability of the findings, additional research is needed.
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healthcare-05-00083-t001_Table 1

###### 

Descriptive statistics for pooled sample and race by gender subgroups.

  --------------------------------------------------------------------------------------------------------------------------------------------
                              Pooled Sample\   White Men\   White Women\   Black Men\   Black Women\                                   
                              *n* = 112        *n* = 26     *n* = 14       *n* = 34     *n* = 38                                       
  --------------------------- ---------------- ------------ -------------- ------------ -------------- ------- ------- ------- ------- -------
  Age (years)                 55.79            8.94         61.46          9.84         60.36          8.34    50.68   7.88    54.82   6.27

  SES                         66.23            16.66        66.19          15.35        62.27          13.66   69.22   14.27   65.01   20.36

  Diabetes duration (years)   13.48            8.84         18.33          13.09        13.82          5.86    12.68   7.00    10.74   6.10

  HbA1c                       8.02             1.87         7.86           1.26         7.09           1.59    8.63    2.22    7.93    1.84
  --------------------------------------------------------------------------------------------------------------------------------------------

SES: Socioeconomic Status; HbA1c: Hemoglobin A1c.

healthcare-05-00083-t002_Table 2

###### 

Pearson correlations for the pooled sample and race by gender subgroups.

                             1       2       3            4            5
  -------------------------- ------- ------- ------------ ------------ ------------
  **Pooled Sample**                                                    
  1 Age                      \-\--   −0.13   0.47 \*\*    0.39 \*\*    −0.32 \*\*
  2 SES                              \-\--   −0.27 \*\*   −0.18 ^\#^   0.02
  3 Governmental insurance                   \-\--        0.01         −0.23 \*
  4 Diabetes duration                                     \-\--        −0.08
  5 HbA1c                                                              \-\--
  **White Men**                                                        
  1 Age                      \-\--   −0.28   0.71 \*\*    0.28         −0.39 \*
  2 SES                              \-\--   −0.25        −0.16        0.04
  3 Governmental insurance                   \-\--        −0.10        −0.29
  4 Diabetes duration                                     \-\--        −0.12
  5 HbA1c                                                              \-\--
  **White Women**                                                      
  1 Age                      \-\--   −0.16   0.79 \*\*    0.47         0.04
  2 SES                              \-\--   −0.48 ^\#^   0.54 ^\#^    −0.27
  3 Governmental insurance                   \-\--        0.28         0.02
  4 Diabetes duration                                     \-\--        −0.26
  5 HbA1c                                                              \-\--
  **Black Men**                                                        
  1 Age                      \-\--   0.01    −0.04        0.36 \*      −0.35 \*
  2 SES                              \-\--   −0.12        −0.24        −0.30 ^\#^
  3 Governmental insurance                   \-\--        −0.26        −0.27
  4 Diabetes duration                                     \-\--        −0.01
  5 HbA1c                                                              \-\--
  **Black Women**                                                      
  1 Age                      \-\--   −0.03   0.34 \*      0.35 \*      −0.23
  2 SES                              \-\--   −0.29 ^\#^   −0.36 \*     0.24
  3 Governmental insurance                   \-\--        0.10         −0.18
  4 Diabetes duration                                     \-\--        −0.06
  5 HbA1c                                                              \-\--

SES: Socioeconomic Status, HbA1c: Hemoglobin A1c. ^\#^: 0.05 ≤ *p* ≤ 0.10 (2-tailed). \*: 0.01 \< *p* \< 0.05 (2-tailed). \*\*: *p* ≤ 0.01 (2-tailed).

healthcare-05-00083-t003_Table 3

###### 

Summary of linear regression in the pooled sample.

  Variable                      Model 1   Model 2                                     
  ----------------------------- --------- ------------- ------- ------- ------------- -------
  Race (Black)                  0.12      −0.39--1.38   0.267   −0.02   −1.17--1.03   0.898
  Gender (female)               −0.19     −1.47--0.04   0.064   −0.44   −3.00--0.32   0.016
  Age (years)                   −0.25     −0.11--0.00   0.046   −0.29   −0.12--0.01   0.022
  SES                           −0.03     −0.03--0.02   0.727   −0.03   −0.03--0.02   0.790
  Governmental insurance        0.11      −0.28--0.82   0.326   0.10    −0.29--0.80   0.360
  Diabetes duration (years)     0.00      −0.05--0.05   0.994   0.00    −0.05--0.05   0.973
  Race × Gender (Black Women)   \-        \-            \-      0.34    −0.24--3.00   0.094

SES: Socioeconomic Status. Outcome is Hemoglobin A1c (HbA1c).

healthcare-05-00083-t004_Table 4

###### 

Summary of linear regression stratified by race by gender groups.

                              White Men   White Women   Black Men   Black Women                                                                             
  --------------------------- ----------- ------------- ----------- ------------- ------------- ------- ------- ------------- ------- ------- ------------- -------
  Age (years)                 −0.46       −0.15--0.04   0.214       0.18          −0.24--0.31   0.762   −0.35   −0.20--0.01   0.040   −0.25   −0.20--0.05   0.217
  SES                         −0.03       −0.04--0.04   0.889       −0.13         −0.12--0.10   0.847   −0.33   −0.10--0.00   0.050   0.27    −0.01--0.06   0.176
  Governmental insurance      −0.06       −1.03--0.88   0.868       0.52          −1.38--2.55   0.482   0.35    0.05--2.42    0.042   0.02    −1.12--1.27   0.902
  Diabetes duration (years)   0.00        −0.05--0.05   0.984       0.03          −0.28--0.29   0.961   −0.08   −0.16--0.10   0.634   0.13    −0.09--0.17   0.544

SES: Socioeconomic Status. Outcome is Hemoglobin A1c (HbA1c).
